Literature DB >> 2333784

Zinc excretion in osteoporotic women.

M Herzberg1, J Foldes, R Steinberg, J Menczel.   

Abstract

The relation of zinc to the aging skeleton was investigated in 140 women aged 36-85 years, mostly postmenopausal, who attended the Jerusalem Osteoporosis Center. Osteoporosis was determined by lumbar spine radiograms (Smith index). Bone density (BD) of the distal radius was assessed by Compton spectroscopy and bone mineral content (BMC) at the same site by single-photon absorptiometry. Urine samples (24 h) were analyzed for zinc (UZn), hydroxyproline (UHP), calcium (UCa), magnesium (UMg), and phosphorus (UP) and expressed per gram creatinine. Patients with definite osteoporosis (n = 94) compared to subjects with borderline or no osteoporosis (n = 34) had a significantly higher mean age (67.4 versus 58.6 years), postmenopausal age (PMA, 19.9 versus 11.0), UZn (811 versus 581), UHP (23.5 versus 18.2), and UMg (90.4 versus 74.3). Urinary calcium UCa and phosphorus UP were similar in both groups. The bone mass measurements BD, BMC, and CI were lower in the osteoporotic group. Hyperzincuria (UZn above 800 micrograms/g creatinine) was found in 41 osteoporotic patients (45%) compared to 6 subjects in the control group (17%). In view of the positive correlation between UZn and age (r = 0.35, p = 0.001) and to eliminate the effect of age, a separate analysis was performed for 66 subjects under the age of 65 in whom the mean age was similar for the osteoporosis patients (n = 38) and control group (n = 28). Nevertheless, the osteoporosis patients still had a significantly higher mean UZn and UHP.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333784     DOI: 10.1002/jbmr.5650050308

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  17 in total

Review 1.  Minerals and osteoporosis.

Authors:  H Rico
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

Review 2.  Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2012-04-05       Impact factor: 3.396

Review 3.  Copper, magnesium, zinc and calcium status in osteopenic and osteoporotic post-menopausal women.

Authors:  Marjan Mahdavi-Roshan; Mehrangiz Ebrahimi; Aliasgar Ebrahimi
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

4.  Biochemical markers of nutrition in osteoporosis.

Authors:  H Rico; P Relea; M Revilla; E R Hernandez; I Arribas; L F Villa
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

5.  Effects of zinc-substituted nano-hydroxyapatite coatings on bone integration with implant surfaces.

Authors:  Shi-fang Zhao; Wen-jing Dong; Qiao-hong Jiang; Fu-ming He; Xiao-xiang Wang; Guo-li Yang
Journal:  J Zhejiang Univ Sci B       Date:  2013-06       Impact factor: 3.066

6.  Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions.

Authors:  Masayoshi Yamaguchi; Maya Goto; Satoshi Uchiyama; Taeko Nakagawa
Journal:  Mol Cell Biochem       Date:  2008-03-09       Impact factor: 3.396

7.  Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.

Authors:  Ellen B Fung; Janet L Kwiatkowski; James N Huang; Ginny Gildengorin; Janet C King; Elliott P Vichinsky
Journal:  Am J Clin Nutr       Date:  2013-08-14       Impact factor: 7.045

Review 8.  Role of nutritional zinc in the prevention of osteoporosis.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2009-12-25       Impact factor: 3.396

9.  Zinc intake and biochemical markers of bone turnover in type 1 diabetes.

Authors:  Raelene E Maser; John N Stabley; M James Lenhard; Phyllis Owusu-Griffin; Michelle A Provost-Craig; William B Farquhar
Journal:  Diabetes Care       Date:  2008-09-22       Impact factor: 19.112

Review 10.  IGF-1, the cross road of the nutritional, inflammatory and hormonal pathways to frailty.

Authors:  Marcello Maggio; Francesca De Vita; Fulvio Lauretani; Valeria Buttò; Giuliana Bondi; Chiara Cattabiani; Antonio Nouvenne; Tiziana Meschi; Elisabetta Dall'Aglio; Gian Paolo Ceda
Journal:  Nutrients       Date:  2013-10-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.